EP2578189A1 — Apparatus for intraocular injection
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-04-10 · 13y expired
What this patent protects
Described is an apparatus for intraocular injection comprising an inner sleeve (38) adapted to accommodate a syringe (32) having a needle (34), a needle cover (36) adapted to cover the needle (34), and an outer sleeve (37) telescopically coupled to the inner sleeve (38). The inne…
USPTO Abstract
Described is an apparatus for intraocular injection comprising an inner sleeve (38) adapted to accommodate a syringe (32) having a needle (34), a needle cover (36) adapted to cover the needle (34), and an outer sleeve (37) telescopically coupled to the inner sleeve (38). The inner sleeve (38) includes a distal end adapted to engage the needle cover (16). Movement of the inner sleeve (38) relative to the outer sleeve (37) causes removal of the needle cover (36) from the needle (34).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.